Lipid Lowering Treatment and Eligibility for PCSK9 Inhibition in Post-Myocardial Infarction Patients in Italy: Insights from Two Contemporary Nationwide Registries. [electronic resource]
Producer: 20200622Description: 3856242 p. digitalISSN:- 1755-5922
- Aged
- Anticholesteremic Agents -- adverse effects
- Biomarkers -- blood
- Cholesterol, LDL -- blood
- Clinical Decision-Making
- Down-Regulation
- Dyslipidemias -- blood
- Eligibility Determination -- trends
- Female
- Humans
- Italy -- epidemiology
- Male
- Middle Aged
- Myocardial Infarction -- diagnosis
- PCSK9 Inhibitors
- Patient Selection
- Practice Patterns, Physicians' -- trends
- Prospective Studies
- Registries
- Secondary Prevention -- trends
- Serine Proteinase Inhibitors -- adverse effects
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.